BIO
Price
$247.35
Change
-$3.46 (-1.38%)
Updated
Jul 15 closing price
Capitalization
9.79B
8 days until earnings call
CPT
Price
$112.48
Change
-$1.62 (-1.42%)
Updated
Jul 15 closing price
Capitalization
10.51B
15 days until earnings call
Interact to see
Advertisement

BIO vs CPT

Header iconBIO vs CPT Comparison
Open Charts BIO vs CPTBanner chart's image
Bio-Rad Laboratories
Price$247.35
Change-$3.46 (-1.38%)
Volume$212.62K
Capitalization9.79B
Camden Property Trust
Price$112.48
Change-$1.62 (-1.42%)
Volume$587.21K
Capitalization10.51B
BIO vs CPT Comparison Chart in %
Loading...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIO vs. CPT commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a StrongBuy and CPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 16, 2025
Stock price -- (BIO: $247.35 vs. CPT: $112.48)
Brand notoriety: BIO and CPT are both not notable
BIO represents the Medical Specialties, while CPT is part of the Real Estate Investment Trusts industry
Current volume relative to the 65-day Moving Average: BIO: 62% vs. CPT: 62%
Market capitalization -- BIO: $9.79B vs. CPT: $10.51B
BIO [@Medical Specialties] is valued at $9.79B. CPT’s [@Real Estate Investment Trusts] market capitalization is $10.51B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Real Estate Investment Trusts] industry ranges from $243.79B to $0. The average market capitalization across the [@Medical Specialties] industry is $8.62B. The average market capitalization across the [@Real Estate Investment Trusts] industry is $5.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIO’s FA Score shows that 0 FA rating(s) are green whileCPT’s FA Score has 0 green FA rating(s).

  • BIO’s FA Score: 0 green, 5 red.
  • CPT’s FA Score: 0 green, 5 red.
According to our system of comparison, both BIO and CPT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIO’s TA Score shows that 6 TA indicator(s) are bullish while CPT’s TA Score has 4 bullish TA indicator(s).

  • BIO’s TA Score: 6 bullish, 3 bearish.
  • CPT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BIO is a better buy in the short-term than CPT.

Price Growth

BIO (@Medical Specialties) experienced а -1.35% price change this week, while CPT (@Real Estate Investment Trusts) price change was -0.73% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.00%. For the same industry, the average monthly price growth was +1.59%, and the average quarterly price growth was -1.40%.

The average weekly price growth across all stocks in the @Real Estate Investment Trusts industry was +0.56%. For the same industry, the average monthly price growth was +2.82%, and the average quarterly price growth was +3.62%.

Reported Earning Dates

BIO is expected to report earnings on Oct 23, 2025.

CPT is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Medical Specialties (-1.00% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Real Estate Investment Trusts (+0.56% weekly)

A real estate investment trust (REIT) is a company any that owns, and in most cases, operates, income-producing real estate – ranging from office and apartment buildings to warehouses, hospitals, shopping centers, hotels and timberlands. Some REITs are involved in financing real estate. Equity REITs invest in and own properties, while mortgage REITs own and invest in property mortgages. REITs are required by law to pay out at least 90% of their annual taxable income (excluding capital gains) to shareholders in the form of dividends. Some REITs could be more cyclical than others; for example, when an economy is undergoing a recession, hotel REITs could be more vulnerable, compared to say healthcare REIT given that healthcare needs are less likely to depend on economic cycles. American Tower Corporation, Prologis, Inc. and Crown Castle International Corp are some of the biggest REIT companies in the U.S.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CPT($10.5B) has a higher market cap than BIO($9.79B). CPT has higher P/E ratio than BIO: CPT (26.06) vs BIO (3.64). CPT YTD gains are higher at: -1.318 vs. BIO (-24.705). CPT has higher annual earnings (EBITDA): 1.12B vs. BIO (-654.76M). BIO has more cash in the bank: 1.61B vs. CPT (260M). BIO has less debt than CPT: BIO (1.41B) vs CPT (3.72B). BIO has higher revenues than CPT: BIO (2.67B) vs CPT (1.54B).
BIOCPTBIO / CPT
Capitalization9.79B10.5B93%
EBITDA-654.76M1.12B-58%
Gain YTD-24.705-1.3181,875%
P/E Ratio3.6426.0614%
Revenue2.67B1.54B173%
Total Cash1.61B260M618%
Total Debt1.41B3.72B38%
FUNDAMENTALS RATINGS
BIO vs CPT: Fundamental Ratings
BIO
CPT
OUTLOOK RATING
1..100
2357
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
10067
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6055
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIO's Valuation (50) in the Medical Specialties industry is in the same range as CPT (50) in the Real Estate Investment Trusts industry. This means that BIO’s stock grew similarly to CPT’s over the last 12 months.

CPT's Profit vs Risk Rating (67) in the Real Estate Investment Trusts industry is somewhat better than the same rating for BIO (100) in the Medical Specialties industry. This means that CPT’s stock grew somewhat faster than BIO’s over the last 12 months.

CPT's SMR Rating (100) in the Real Estate Investment Trusts industry is in the same range as BIO (100) in the Medical Specialties industry. This means that CPT’s stock grew similarly to BIO’s over the last 12 months.

CPT's Price Growth Rating (55) in the Real Estate Investment Trusts industry is in the same range as BIO (60) in the Medical Specialties industry. This means that CPT’s stock grew similarly to BIO’s over the last 12 months.

CPT's P/E Growth Rating (100) in the Real Estate Investment Trusts industry is in the same range as BIO (100) in the Medical Specialties industry. This means that CPT’s stock grew similarly to BIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOCPT
RSI
ODDS (%)
Bearish Trend 1 day ago
60%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
65%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
49%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
49%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
52%
Advances
ODDS (%)
Bullish Trend 6 days ago
67%
Bullish Trend 2 days ago
60%
Declines
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 7 days ago
52%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WOGSX149.02N/A
N/A
White Oak Select Growth
BIAUX28.01N/A
N/A
Brown Advisory Small-Cap Fdmtl Val Inv
FZALX29.07N/A
N/A
Fidelity Advisor Mega Cap Stock Z
JEVCX9.80N/A
N/A
JHancock Disciplined Value Em Mkts Eq C
RLBCX36.49-0.14
-0.38%
American Funds American Balanced R3